EZSolution™ Tandutinib

A 10 mM (5 mg in 888 µl) of the potent inhibitor of FLT kinase, PDGFRβ and c-Kit Tandutinib (Cat. No. 2024) in anhydrous DMSO.

Alternate Name/Synonyms: CT53518, 4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide, CT53518

Appearance: Liquid

Appearance: A 10 mM solution in anhydrous DMSO

Appearance: 387867-13-2

Appearance: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₃₁H₄₂N₆O₄

Molecular Weight: 562.7

Cell-Permeable?: True

Purity: ≥98% by HPLC

Solubilities:

Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.

Country of Origin: USA

Tag Line: A potent inhibitor of FLT kinase, PDGFRβ and c-Kit

MDL Number:

PubChem CID: 3038522

SMILES: CC(C)OC1=CC=C(C=C1)NC(=O)N2CCN(CC2)C3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCCC5

InChi: InChI=1S/C31H42N6O4/c1-23(2)41-25-10-8-24(9-11-25)34-31(38)37-17-15-36(16-18-37)30-26-20-28(39-3)29(21-27(26)32-22-33-30)40-19-7-14-35-12-5-4-6-13-35/h8-11,20-23H,4-7,12-19H2,1-3H3,(H,34,38)

InChi Key: UXXQOJXBIDBUAC-UHFFFAOYSA-N

Category: Biochemicals